LFSC

F/m Emerald Life Sciences Innovation ETF

46.82

Aug 13 • 3:50 PM ET -0.36 (-0.76%)

46.83

Aftermarket • 7:34 PM ET +0.01 (0.03%)

Financial Exchange Traded Fund USA NASD

Category	US Equities - Industry Sector
Sponsor	F/m Investments
Fund Family
Index	-
Index Weighting
Active/Passive
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Expense	0.54%
Inverse/Leveraged
IPO	Oct 31, 2024

Asset Type	Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	No / Yes

Tags	Developed
Tags	equity
Tags	innovation
Tags	healthcare
Tags	biotechnology
Tags	medical
Tags	pharmaceutical
Sector/Theme
Region
SMA20	1.65%
SMA50	5.93%
SMA200	22.53%

Return% 1Y	82.46%
Return% 3Y	-
Return% 5Y	-
Return% 10Y
Return% SI
Flows% 1M	0.72%
Flows% 3M	2.75%
Flows% YTD	7.01%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	38
AUM	129.62M
NAV/sh
52W High	47.68 -1.80%
52W Low	26.75 75.03%
Volatility	0.83% 1.42%
ATR (14)	0.84
RSI (14)	55.89
Beta	0.92
Rel Volume	0.39
Avg Volume	4.53K
Volume	1,772

Perf Week	1.21%
Perf Month	1.32%
Perf Quarter	20.97%
Perf Half Y	30.22%
Perf YTD	27.88%
Perf Year	72.93%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Prev Close	47.18
Price	46.82
Change %	-0.76%

Jan-22-26 12:51PM	FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer (Benzinga)
Jan-14-26 06:44AM	Travere Stock Slips After FDA Delays Review Of Key Kidney Drug (Benzinga)
Dec-31-25 11:00AM	Best-Performing Active ETFs of 2025 (Zacks)
Feb-04-25 10:15AM	Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference (Business Wire)
Oct-31-24 07:30AM	Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC) (Business Wire)

F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

open in yahoo | open in marketwatch | open in google

LFSC

F/m Emerald Life Sciences Innovation ETF

Upgrade your Finviz experience